Corrections
Corrections: Association of intrarenal blood flow with renal function and target organ damage in hypertensive patients with fibromuscular dysplasia: the ARCADIA‑POL study
CC BY-NC-SA 4.0
Corrections: Association of intrarenal blood flow with renal function and target organ damage in hypertensive patients with fibromuscular dysplasia: the ARCADIA‑POL study
CC BY-NC-SA 4.0
In the Original Article entitled “Association of intrarenal blood flow with renal function and target organ damage in hypertensive patients with fibromuscular dysplasia: the ARCADIA‑POL study” published in the April 2019 issue (Januszewicz M, Januszewicz A, Michałowska I, et al. Pol Arch Intern Med. 2019; 129 (4): 234–241). doi:10.20452/pamw.4479) Table 4 was omitted. The table was added on page 241 of the article, as below.
Table 4. Renal arteries with no fibromuscular dysplasia lesions, fibromuscular dysplasia and nonsignificant renal artery stenosis, fibromuscular dysplasia and significant renal artery stenosis
Parameter | Renal arteries without FMD lesions (1) (n = 84) | Renal arteries with FMD lesions without significant RAS (2) (n = 180) | Renal arteries with FMD lesions and significant RAS (3) (n = 37) RAS | P value | |||
ANOVA | 1 vs 2 | 1 vs 3 | 2 vs 3 | ||||
Data are presented as mean (SD).
Abbreviations: AT, acceleration time; PI, pulsatility index; RAR, renal aortic ratio; Vmax, maximal blood flow velocity; others, see Table 1 | |||||||
Length of kidney, mm | 112.4 (10.1) | 108.4 (10.7) | 107.4 (8.2) | 0.05 | 0.09 | 0.14 | 1.00 |
Vmax, cm/s | 116.0 (43.8) | 151.7 (57.7) | 314.8 (105.6) | <0.001 | <0.001 | <0.001 | <0.001 |
RAR | 1.18 (0.47) | 1.89 (0.75) | 4.19 (2.09) | <0.001 | 0.005 | <0.001 | <0.001 |
RRI | 0.60 (0.06) | 0.59 (0.07) | 0.47 (0.09) | <0.001 | 0.50 | <0.001 | <0.001 |
AT | 20.2 (7.6) | 24.2 (12.2) | 61.4 (32.0) | <0.001 | 0.16 | <0.001 | <0.001 |
PI | 1.08 (0.18) | 1.09 (0.19) | 1.12 (0.22) | 0.64 | 1.00 | 1.00 | 1.00 |
The article is correct at www.mp.pl/paim.